Attention Deficit Hyperactivity Disorder. Disturbance of activity and attention
Conditions
Interventions
Intervention 1: Intervention 1: buspirone was initiated with 0/5 mg/kg/day to maximum 45mg/day. Intervention 2: Intervention 2: Methylphenidate was initiated with 0/5 mg/kg/day and adjusted to maximum
Treatment - Drugs
Intervention 1: buspirone was initiated with 0/5 mg/kg/day to maximum 45mg/day
Intervention 2: Methylphenidate was initiated with 0/5 mg/kg/day and adjusted to maximum 60 mg per day
Sponsors
Behavioral Sciences and Research Center of Shahid Beheshti University of Medical Sciences.
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: ADHD diagnosis according to DSM-VI criteria that scored above 20 in ADHD-Rating Scale. Exclusion criteria: evidence of a mental retardation or a major psychiatric problem other than oppositional defiant disorder and conduct disorder or receiving any psychotropic medication through 2 weeks before initiating treatment; medical disorders that would preclude the safe use of methylphenidate or buspirone.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hyperactivity, impulsivity and inattention symptoms according to parent and teacher point of view. Timepoint: baseline, 2, 4 and 6 weeks after the medications started. Method of measurement: ADHD Rating Scale,(parent and teacher form). | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: every 2 weeks. Method of measurement: check list. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed